Organ donation after circulatory death: the forgotten donor? by Rady, Mohamed Y et al.
Page 1 of 3
(page number not for citation purposes)
Available online http://ccforum.com/content/10/5/166
Abstract
Donation after circulatory death (DCD) can be performed on
neurologically intact donors who do not fulfill neurologic or brain
death criteria before circulatory arrest. This commentary focuses
on the most controversial donor-related issues anticipated from
mandatory implementation of DCD for imminent or cardiac death in
hospitals across the USA. We conducted a nonstructured review
of selected publications and websites for data extraction and
synthesis. The recommended 5 min of circulatory arrest does not
universally fulfill the dead donor rule when applied to otherwise
neurologically intact donors. Scientific evidence from extra-
corporeal perfusion in circulatory arrest suggests that the
procurement process itself can be the event causing irreversibility
in DCD. Legislative abandonment of the dead donor rule to permit
the recovery of transplantable organs is necessary in the absence
of an adequate scientific foundation for DCD practice. The
designation of organ procurement organizations or affiliates to
obtain organ donation consent introduces self-serving bias and
conflicts of interest that interfere with true informed consent. It is
important that donors and their families are not denied a ‘good
death’, and the impact of DCD on quality of end-of-life care has not
been satisfactorily addressed to achieve this.
Introduction
A mandatory implementation of donation after circulatory
death (DCD) from eligible patients facing imminent or cardiac
death in hospitals across the USA was introduced at a
national conference and is to be effective from January 2007
[1]. The DCD requirement is focused on patients who are
neurologically intact or do not fulfill neurologic death criteria
before withdrawal of ventilator support [2]. The mandatory
requirement will be implemented through the collaboration of
the Institute of Medicine, Joint Commission on Accreditation
of Healthcare Organizations, Center for Medicare and
Medicaid Services, and the Department of Health and Human
Services (see the glossary of terms in Table 1) [3,4].
The transplantation community has been reorganized into 58
donation service areas (DSAs) to cover the entire country [5].
Each DSA is centered on one organ procurement organization
(OPO) that facilitates the recovery and flow of transplantable
organs from donor hospital(s) to regional transplant center(s)
within a defined geographic location. Each of the DSAs will
have to meet a target goal of 75% or higher of cadaveric
organ donation rate from its affiliated hospitals.
Determination of circulatory death for organ
procurement
The uniform determination of death relies on irreversible
cessation of circulatory or neurologic function. The unitarian
determination of death by either neurologic or circulatory
criteria rather than fulfilling both criteria simultaneously is
accepted as the standard for cadaveric organ procurement
[2]. The DCD criteria relies on expert opinion, which permits
the procurement process after 5 min of apnea, unresponsive-
ness, and pulselessness [6].
The pivotal assumption that DCD will eliminate the possibility
that the procurement process is the direct cause of death has
been challenged. Spontaneous return of both circulatory and
neurologic function (autoresuscitation or Lazarus
phenomenon) has been reported after 10 min of electric
asystole [7]. The notion of a specific time interval for
determination of irreversible cessation of circulatory function
is also difficult to reconcile with the dead donor rule, when
extracorporeal circulation and oxygenation during
procurement are used to maintain organ viability in DCD [8].
Return of full neurologic function during extracorporeal
circulation is well documented in victims of in-hospital and
out-of-hospital cardiac arrest, because they are neurologically
intact before circulatory death [9,10]. Artificial circulatory
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support can also lead to cerebral and coronary resuscitation,
and reanimation or return to life, which have to be
suppressed by aortic balloon occlusion during procurement
[8].
The DCD is applied to many individuals with intact neurologic
and brain function before circulatory arrest, and therefore the
presence of neurologic or brain activity during procurement is
relevant [1,5]. There are no published reports of spontaneous
neurologic or cardiac recovery or return to life during procure-
ment in DCD. However, it may not be feasible to obtain that
type of evidence if the procurement process itself is the final
cause of irreversibility. Also, such reporting will probably
create medicolegal concerns within the community. Under
such circumstances, organ donation can no longer be
considered to fulfill the dead donor rule. Legislative
abandonment of the dead donor rule has been proposed for
procurement of transplantable organs because of lack of
sufficient scientific foundation for current DCD practice [11].
Consent for organ procurement
The OPO or affiliates are the designated ‘organ requesters’ in
the organ donation consent process [5]. Hospitals are
required to notify the OPO of all imminent deaths early and
before withdrawal of ventilator support in order to initiate
independently the discussion and consent process for organ
donation with surrogates [3]. The conflict of interest and self-
serving bias of the OPO can limit the exchange of information
with surrogates and violate the standards for true informed
consent. The objective of OPOs is to obtain consent for
organ donation and meet the target donation rate within each
DSA [5]. The interlinking of OPO, donor, and transplant
hospitals within a DSA can also heighten financial interests to
maximize organ donation consent.
The donor’s authorization for donation on an organ donor
card, driver’s license, or donor registry is legally binding and
irrevocable, so in such cases the OPO can procure organs
without family consent or after refusal [3]. Presumed consent
has also been proposed to facilitate OPO recovery of
transplantable organs [2]. In presumed consent, agreement
for donation is the default choice, in the absence of express
rejection by the potential donor. Therefore, in the absence of
an individual’s express decision, their consent rather than
refusal for organ donation is presumed. The legislative
enactment of presumed consent enables the OPO to
override donation refusal by surrogates. A conscription model
has also been proposed so that consent for organ donation
will neither be required nor requested by the OPO because
of compulsory requirement for removal of all needed
transplantable cadaveric organs [2].
End-of-life care
OPO staff officially assume planning of medical care of the
donor after organ donation consent has been established, in
order to maintain organs viability and prepare for their
procurement [12]. Compliance with metrics for quality of end-
of-life (EOL) care has been emphasized to deliver patient and
family centered care and to ensure a ‘good death’ experience
in the intensive care unit (ICU; Table 2) [13]. The quality of
EOL care has not been measured nor reported for ICU
donors enrolled in DCD programs [1]. DCD enrollment is
Table 1
Glossary of terms used
Term Details
Center for Medicare and  A government agency in charge of providing health care and services to the elderly (≥65 years) and 
Medicaid Services individuals without health insurance in the USA
Circulatory death Irreversible cessation of circulation and cardiac mechanical pump activity
Department of Health and  A government agency with oversight on the development and implementation of health care policy in the USA
Human Services
Donation service area (DSA) The administrative and operational joining of an organ procurement organization with its regional donor and 
transplant hospitals within the assigned geographic location
Joint Commission on  A nongovernmental commission responsible for the safety and quality of care provided by health care 
Accreditation of Healthcare  organizations (for instance, hospitals) through the provision of health care accreditation and related services 
Organizations that support performance improvement
Institute of Medicine A nonprofit private organization providing independent, objective, and evidence-based advice to policy 
makers, health professionals, the private sector, and the public on matters of biomedical science, medicine, 
and health
Neurologic death Irreversible cessation of all neurologic, including brain stem, activity
Organ procurement organization  A private, nonprofit organization operating under government contract to provide services covering all 
(OPO) aspects of cadaveric organ donation, including donor selection, consenting, preparation, recovery and 
transportation of procured organs. Each organization is assigned to a specific geographic area with a total of 
58 organizations covering the 52 states of the USAPage 3 of 3
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expected to deviate from more than 60% of the EOL care
quality indicators (Table 2).
Ante mortem invasive instrumentation and testing that are
nonbeneficial and perhaps harmful interventions that expedite
death are often performed in preparation for DCD. The
Wisconsin protocol is used to select suitable candidates for
DCD [1]. The protocol is intended to predict whether
circulatory arrest can occur within 60 min of withdrawal of life
support. The high false-positive rate for selection of DCD
candidates in the ICU can expose many dying ICU patients to
unnecessary ante mortem interventions [14]. The quality of
EOL care also has profound psychologic sequelae for
families. Post-traumatic stress reaction has been reported in
family members of ICU patients who share in EOL decisions
[15]. Organ donation is a stressful and difficult EOL decision
that can lead to anxiety, depression, and decreased quality of
life among family members of the deceased donor.
Conclusion
The DCD criteria do not universally fulfill the dead donor rule.
Therefore, legislative abandonment of the dead donor rule to
permit the recovery of transplantable organs is necessary
because of lack of adequate scientific foundation for DCD
practice. The conflict of interest and self-serving bias of
OPOs can interfere with a true informed consent for organ
donation. Finally, mandatory compliance with EOL care
metrics can ensure that donor care is not sacrificed for the
recovery of transplantable organs.
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Table 2
Compliance of DCD with the quality indictors for EOL care in the donor
Domains for EOL care Quality indicators DCD compliance
Patient and family-centered decision making 13 8
Communication within the team and with patients and families 10 4
Continuity of care 3 0
Emotional and practical support for patients and families 8 4
Symptom management and comfort care 10 1
Spiritual support for patients and families 3 1
Emotional and organizational support for ICU clinicians 6 1
Total 53 19
The 53 quality indicators within seven domains were developed by The Robert Wood Johnson Foundation Critical Care End-Of-Life Peer
Workgroup [13]. The DCD is expected to comply with 19 out of 53 quality indicators for EOL care in the potential donor. DCD, donation after
circulatory death; EOL, end-of-life; ICU, intensive care unit.